The purpose of the study is to evaluate the clinical and technical success as well as safety and feasibility of the E-liac Stent Graft System used in endovascular treatment of uni- or bilateral aortoiliac or iliac aneurysm. Main study target is the exclusion of aneurysm with primary patency of the arteria iliaca interna and the arteria iliaca externa on iliac implantation side.
Study Type
OBSERVATIONAL
Enrollment
47
Implantation of the E-liac Stent Graft System in combination with a peripheral covered stent and in case of aortoiliac aneurysm in combination with a AAA Stent Graft
Herzzentrum Hietzing
Vienna, Austria
Wilhelminenspital
Vienna, Austria
German Heart Center
Berlin, Germany
Klinikum Chemnitz
Primary patency
Primary patency of the arteria iliaca interna and the arteria iliaca externa on E-liac implantation side
Time frame: within 30 days
Primary Patency
Time frame: 12 months
Primary patency
Time frame: 36 months
Endoleak Type I or III
Time frame: within 30 days
Endoleak Type I or III
Time frame: 12 months
Endoleak Type I or III
Time frame: 36 months
Change in aneurysm size
Time frame: within 30 days (baseline) and 36 months
Stent graft migration
Time frame: within 30 days (baseline) and 36 months
Stent graft dislodgement
Time frame: 36 months
Stent graft kinking
Time frame: 36 months
Distal embolization
Time frame: 36 months
Rate of death
Time frame: 36 months
Rate of complications
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Chemnitz, Germany
Cologne University Hospital
Cologne, Germany
Uniklinikum Düsseldorf
Düsseldorf, Germany
UKSH Campus Kiel
Kiel, Germany
Krankenhaus Leonberg
Leonberg, Germany
Marienhospital
Osnabrück, Germany
Instytut Hematologii i Transfuzjologii
Warsaw, Poland
...and 2 more locations
Time frame: 36 months